Disclosures for "Clinical and Biological Predictors of Quality of Life in CASPR2-antibody Encephalitis"
-
Author has nothing to disclose
-
Dr. Ayoub has nothing to disclose.
-
Dr. Strippel has nothing to disclose.
-
Dr. Michael has received personal compensation for serving as an employee of Eisai.
-
Dr. Uy has received personal compensation in the range of $500-$4,999 for serving as a IVIG for CNS Disease Task Force Member with Provincial Blood Coordinating Office (British Columbia).
-
Dr. Dawes has nothing to disclose.
-
Prof. Bennett has a non-compensated relationship as a Consultant with AditumBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with AstraZeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biogen that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Biointervene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Combigene that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with LatigoBio that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with GSK that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Ionis that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Lexicon therapeutics that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Neuvati that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Novo Ventures 2023 that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consutlant with Olipass that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Orion that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Replay that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with SC Health Managers that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Third Rock ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a Consultant with Vida Ventures that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Lily that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received research funding with Astra Zeneca that is relevant to AAN interests or activities. Prof. Bennett has a non-compensated relationship as a received an industrial partnership grant from AZ & the BBSRC with Astra Zeneca that is relevant to AAN interests or activities.
-
The institution of Dr. Binks has received research support from Wellcome Trust. The institution of Dr. Binks has received research support from PetSavers. The institution of Dr. Binks has received research support from PetPlan. The institution of Dr. Binks has received research support from NIHR. The institution of Dr. Binks has received research support from Morris Animal Foundation. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Dr. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Scientific Panel Member with Encephalitis International that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Editorial Fellow with JAMA Neurology that is relevant to AAN interests or activities.
-
The institution of Adam Handel has received research support from Medical Research Council (UK). The institution of Adam Handel has received research support from UCB-Pharma. The institution of Adam Handel has received research support from MyAware.
-
Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.